Please Wait.....
Report
Nutraceutical Ingredients Market by Type (Proteins, Amino Acids, and Probiotics), Application (Food, Beverages, Animal Nutrition, Dietary Supplements, Food For Special Medical Purposes (FSMP)), Form, Function, & Region - Global Forecast to 2029
Market Report I 2024-07-30 I 618 Pages I MarketsandMarkets
The global nutraceutical ingredients market is on a trajectory of significant expansion, with an estimated value projected to reach USD 136.1 billion by 2029 from the 2024 valuation of USD 105.2 billion, displaying a promising Compound Annual Growth Rate (CAGR) of 5.3%.
"Regulatory support and collaborative efforts across public and private sectors in eradicating undernourishment fuels the demand for nutraceutical ingredients market."
In order to combat widespread deficiencies, governments and non-governmental organisations (NGOs) are championing initiatives that highlight the significance of nutrition. Large-scale food fortification initiatives, for instance, have greatly increased the global adoption of fortified foods. These initiatives are supported by organisations such as PATH (Program for Appropriate Technology in Health). PATH's nutrient-fortifying rice kernels (UltraRice) initiative has proven scalable and effective in Burundi, India, Brazil, and other countries, impacting regulatory frameworks and nutritional policies. In addition to addressing nutritional deficiencies, these initiatives establish guidelines that promote the use of fortified ingredients in food processing.
Nutraceutical ingredients are becoming more and more popular in animal nutrition to improve feed formulations. Improved feed additives aim to enhance animal health, growth efficiency, and product quality, meeting the rising demand for high-quality protein sources globally.
Partnerships within the industry further accelerate market expansion. For instance, Olam Agri Holdings Pte Ltd has committed to fortifying staple foods with essential micronutrients at scale, so millions can be reached every day by 2030. Such initiatives promote the industry's dedication to sustainability and public health while accelerating the global uptake of fortified foods. The market is anticipated to grow further due to ongoing innovation, regulatory support, and cross-sector collaboration, solidifying nutraceutical ingredients' position as a key component of global health and wellness initiatives in the future.
"During the forecast period, the food for special medical purposes (FSMP) within the application segment is estimated to witness the highest CAGR in the nutraceutical ingredients market."
Food specially prepared to meet special, often disease- or medical-condition-related nutritional requirements of individuals is known as food for special medical purposes. The increasing prevalence of chronic diseases and disorders, such as diabetes, gastrointestinal problems, metabolic syndromes, and others, has been the primary driver for the ever-growing demand for nutraceutical ingredients in FSMP. For instance, the IDF Diabetes Atlas for 2021 estimates that 1 in 10 adults worldwide, or 537 million adults aged 20 to 79, have diabetes at present. By 2030, this number is expected to rise to 643 million, and by 2045, it is expected to reach 783 million. Among the specific health benefits that nutraceutical ingredients provide to these patient populations are symptom management, improved nutritional intake, and support for overall health.
Moreover, the prevalence of food allergies and intolerances has heightened the need for specialized FSMP formulations that are free from allergens and tailored to individual dietary restrictions. This necessitates the addition of nutraceutical ingredients that are not only safe but have the efficacy to meet nutritional requirements without adverse reactions. Regulatory agencies, which provide support through developments in medical nutrition therapies, are also boosting this segment by ensuring that stringent health standards are met while allowing innovations in ingredient formulation.
"High healthcare costs driving demand for preventive healthcare have positioned the US in North America region as the dominant market in the nutraceutical ingredients market."
The US holds a dominant position in the North American nutraceutical ingredients market. There is a great need for preventive healthcare solutions due to the high cost of healthcare in the country. According to a piece by the PETER G. Peterson Foundation, US healthcare spending hit USD 4.5 trillion in 2022, or USD 13,493 per person, much more than in other wealthy countries. Due to such high healthcare costs, Americans are encouraged to spend money on nutraceutical ingredients and other preventive measures in order to maintain their health and lower their long-term medical costs.
A 2023 CRN Consumer Survey on Dietary Supplements stated that 74 percent of US adults take dietary supplements, with 55 percent among them taking them regularly. This simply indicates the importance of dietary supplements in promoting health in the nation. The desire for proactive health management in the face of rising healthcare costs and rising consumer awareness are the driving forces behind this widespread use. This growth is also supported by strong research and development activities and a very encouraging regulatory environment that allows innovation in health products. Businesses in the US are better able to develop and commercialize innovative nutraceutical ingredients because of their sophisticated infrastructure and highly qualified workforce.
The break-up of the profile of primary participants in the nutraceutical ingredients market:
- By Company Type: Tier 1 - 51%, Tier 2 - 26%, and Tier 3 - 23%
- By Designation: CXO's - 24%, Managers - 43%, Executives- 33%
- By Region: North America - 25%, Europe - 20%, Asia Pacific - 45%, South America - 5%, and Rest of the World -5%
Prominent companies include Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF SE (Germany), Arla Foods amba (Denmark), Associated British Foods plc (UK), dsm-firmenich (Switzerland), Ingredion (US), Tate & Lyle (UK), Ajinomoto Co., Inc. (Japan), and Chr. Hansen A/S (Denmark).
Research Coverage:
This research report categorizes the nutraceutical ingredients market by applications (food, beverages, animal nutrition, dietary supplements, and foods for special medical purposes (FSMP)), type (proteins, amino acids, fibers & specialty carbohydrates, probiotics, phytochemicals & plant extracts, prebiotics, functional fats & oils, vitamins, minerals, carotenoids, and other types), form (dry and liquid), function (qualitative), and region (North America, Europe, Asia Pacific, South America, and Rest of the World).
The report covers information about the key factors, such as drivers, restraints, opportunities, and challenges impacting the growth of the nutraceutical ingredients market. It also provides a detailed analysis of the major players in the market including their business overview, products offered; key strategies; partnerships, new product launches, expansions, and acquisitions. Competitive benchmarking of upcoming startups in the nutraceutical ingredients market is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall nutraceutical ingredients market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (Growing demand for fortified food due to increased health consciousness
among consumers), restraints (Higher costs of fortified products dissuade large-scale usage and adoption), opportunities (Nutraceuticals as alternatives for pharmaceuticals), and challenges (Combating counterfeiting in the nutraceutical industry) influencing the growth of the nutraceutical ingredients market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the nutraceutical ingredients market.
- Market Development: Comprehensive information about lucrative markets - the report analyses the nutraceutical ingredients market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the nutraceutical ingredients market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF SE (Germany), Arla Foods amba (Denmark), Associated British Foods plc (UK), dsm-firmenich (Switzerland), Ingredion (US), Tate & Lyle (UK), Ajinomoto Co., Inc. (Japan), and Chr. Hansen A/S (Denmark) among others in the nutraceutical ingredients market strategies. The report also helps stakeholders understand the nutraceutical ingredients market and provides them with information on key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION 51
1.1 STUDY OBJECTIVES 51
1.2 MARKET DEFINITION 52
1.3 STUDY SCOPE 52
1.3.1 MARKET SEGMENTATION 53
1.3.2 INCLUSIONS & EXCLUSIONS 54
1.3.3 YEARS CONSIDERED 55
1.4 UNIT CONSIDERED 56
1.4.1 CURRENCY CONSIDERED 56
1.4.2 VOLUME UNIT CONSIDERED 57
1.5 STAKEHOLDERS 57
1.6 SUMMARY OF CHANGES 58
2 RESEARCH METHODOLOGY 59
2.1 RESEARCH DATA 59
2.1.1 SECONDARY DATA 60
2.1.1.1 Key data from secondary sources 60
2.1.2 PRIMARY DATA 61
2.1.2.1 Key data from primary sources 61
2.1.2.2 Key insights from industry experts 62
2.1.2.3 Breakdown of primary interviews 62
2.2 MARKET SIZE ESTIMATION 63
2.2.1 BOTTOM-UP APPROACH 63
2.2.2 TOP-DOWN APPROACH 65
2.2.3 SUPPLY-SIDE ANALYSIS 65
2.2.4 DEMAND-SIDE ANALYSIS 66
2.3 DATA TRIANGULATION 68
2.4 RESEARCH ASSUMPTIONS 69
2.5 LIMITATIONS AND RISK ASSESSMENT 70
3 EXECUTIVE SUMMARY 71
4 PREMIUM INSIGHTS 78
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL INGREDIENTS MARKET 78
4.2 ASIA PACIFIC NUTRACEUTICAL INGREDIENTS MARKET, BY KEY TYPE AND COUNTRY 79
4.3 NUTRACEUTICAL INGREDIENTS MARKET: REGIONAL SNAPSHOT 79
4.4 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE AND REGION 80
4.5 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION AND REGION 81
4.6 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM AND REGION 82
5 MARKET OVERVIEW 83
5.1 INTRODUCTION 83
5.2 MACROECONOMIC INDICATORS 83
5.2.1 DEVELOPMENTS IN RETAIL INDUSTRY 83
5.2.2 RISE IN NUMBER OF DUAL-INCOME HOUSEHOLDS 84
5.3 MARKET DYNAMICS 85
5.3.1 DRIVERS 85
5.3.1.1 Growing demand for fortified food due to increased health consciousness 85
5.3.1.2 Rising incidences of chronic diseases 87
5.3.1.3 Mandates on food fortification by government organizations 88
5.3.1.4 Rise in awareness about feed quality 92
5.3.1.5 Increase in personalized nutrition trends 92
5.3.1.6 Rise in digital health platforms and wearable & implantable technologies 93
5.3.2 RESTRAINTS 94
5.3.2.1 Higher costs of fortified products dissuade large-scale usage and adoption 94
5.3.3 OPPORTUNITIES 95
5.3.3.1 Rising use of nutraceuticals as alternatives for pharmaceuticals 95
5.3.3.2 Alternative sources to obtain functional fats & oils 96
5.3.4 CHALLENGES 97
5.3.4.1 Proliferation of counterfeit products 97
5.3.4.2 Lack of consistency in regulations pertaining to various ingredients 98
6 INDUSTRY TRENDS 100
6.1 INTRODUCTION 100
6.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 101
6.3 PRICING ANALYSIS 101
6.3.1 AVERAGE SELLING PRICE TREND, BY TYPE 101
6.3.2 AVERAGE SELLING PRICE TREND, BY REGION 102
6.4 VALUE CHAIN ANALYSIS 104
6.4.1 RAW MATERIAL SOURCING 104
6.4.2 PRODUCTION & PROCESSING 105
6.4.3 DISTRIBUTION 105
6.4.4 END USERS 105
6.5 ECOSYSTEM 105
6.5.1 DEMAND SIDE 105
6.5.1.1 Ingredient manufacturers 105
6.5.1.2 Technology providers 106
6.5.1.3 Start-ups/emerging companies 106
6.5.2 SUPPLY SIDE 106
6.5.2.1 Regulatory bodies 106
6.5.2.2 End users 107
6.6 TECHNOLOGY ANALYSIS 109
6.6.1 KEY TECHNOLOGIES 109
6.6.1.1 CRISPR and gene editing 109
6.6.2 COMPLEMENTARY TECHNOLOGIES 109
6.6.2.1 Microencapsulated powder for probiotic action in food products 109
6.6.2.2 Robotics leading to innovations in market 110
6.6.2.3 Hologram sciences-platform for personalized nutrition and advice 110
6.6.3 ADJACENT TECHNOLOGIES 110
6.6.3.1 3D printing 110
6.7 PATENT ANALYSIS 111
6.8 TRADE ANALYSIS 116
6.8.1 EXPORT SCENARIO OF NUTRACEUTICAL INGREDIENTS 116
6.8.1.1 Import scenario of nutraceutical ingredients 117
6.9 KEY CONFERENCES AND EVENTS, 2024-2025 119
6.10 TARIFF AND REGULATORY LANDSCAPE 120
6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 120
6.10.2 REGULATORY FRAMEWORK 123
6.10.2.1 Organizations/Regulations governing nutraceutical ingredients market 123
6.10.2.2 North America 125
6.10.2.2.1 Canada 125
6.10.2.2.2 US 125
6.10.2.2.3 Mexico 125
6.10.2.3 European Union (EU) 125
6.10.2.4 Asia Pacific 125
6.10.2.4.1 Japan 125
6.10.2.4.2 China 126
6.10.2.4.3 India 126
6.10.2.4.4 Australia & New Zealand 126
6.10.2.5 Rest of the World (RoW) 126
6.10.2.5.1 Brazil 126
6.10.2.6 Probiotics 126
6.10.2.6.1 Introduction 126
6.10.2.6.2 National/International bodies for safety standards and regulations 127
6.10.2.6.3 North America: Regulatory environment analysis 127
6.10.2.6.4 Europe: Regulatory environment analysis 129
6.10.2.6.5 Asia Pacific: Regulatory environment analysis 129
6.10.2.6.6 South America: Regulatory environment analysis 130
?
6.10.2.7 Prebiotics 131
6.10.2.7.1 Introduction 131
6.10.2.7.2 Asia Pacific 131
6.10.2.7.3 North America 132
6.10.2.7.4 European Union 133
6.11 PORTER'S FIVE FORCES ANALYSIS 134
6.11.1 INTENSITY OF COMPETITIVE RIVALRY 135
6.11.2 THREAT OF NEW ENTRANTS 135
6.11.3 THREAT OF SUBSTITUTES 136
6.11.4 BARGAINING POWER OF SUPPLIERS 136
6.11.5 BARGAINING POWER OF BUYERS 136
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 137
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 137
6.12.2 BUYING CRITERIA 138
6.13 CASE STUDY ANALYSIS 139
6.13.1 FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY 139
6.13.2 MAGNITUDE BIOSCIENCES AND AB BIOTEK HNH EVALUATED PROBIOTIC DEVELOPMENT WITH ETHICAL AND HIGH-THROUGHPUT TESTING 140
6.13.3 ROQUETTE FRERES ACHIEVED COMPLETE AMINO ACID PROFILE WITH NUTRALYS PEA PROTEIN 140
6.14 INVESTMENT AND FUNDING SCENARIO 141
6.15 IMPACT OF GEN AI ON FOOD & BEVERAGE INGREDIENTS/ADDITIVES 141
6.15.1 USE OF GEN AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES 142
6.15.2 CASE STUDIES FOR GENERATIVE AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES 143
6.15.2.1 Flavor and ingredient innovation 143
6.15.2.2 AI-enabled digital tools for consumer understanding and product development 143
6.15.2.3 Personalized AI-developed nutrition platform 144
6.15.2.4 AI and cloud technology to address challenges in F&B industry 145
6.15.3 IMPACT OF GENERATIVE AI/AI ON NUTRACEUTICAL INGREDIENTS MARKET 145
6.15.4 ADJACENT ECOSYSTEM WORKING ON GENERATIVE AI 146
7 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE 147
7.1 INTRODUCTION 148
7.2 PROTEINS 152
7.3 AMINO ACIDS 155
7.3.1 BRANCHED CHAIN AMINO ACIDS 158
7.3.1.1 Leucine 160
7.3.1.2 Isoleucine 161
7.3.1.3 Valine 162
7.3.2 LYSINE 162
7.3.3 METHIONINE 163
7.3.4 THREONINE 164
7.3.5 TRYPTOPHAN 165
7.3.6 GLUTAMIC ACID 166
7.3.7 PHENYLALANINE 167
7.3.8 OTHER AMINO ACID TYPES 168
7.4 FIBERS & SPECIALTY CARBOHYDRATES 169
7.5 PROBIOTICS 172
7.6 PHYTOCHEMICALS & PLANT EXTRACTS 175
7.7 PREBIOTICS 177
7.8 FUNCTIONAL FATS & OILS 180
7.8.1 POLYUNSATURATED FATTY ACIDS (PUFAS) 183
7.8.1.1 Omega-3 fatty acids 184
7.8.1.2 Omega-6 fatty acids 185
7.8.1.3 Conjugated Linoleic Acid (CLA) 186
7.8.2 OMEGA-9 FATTY ACIDS 187
7.8.3 MEDIUM CHAIN TRIGLYCERIDES 188
7.8.4 OTHER FUNCTIONAL FATS & OILS 189
7.9 VITAMINS 190
7.9.1 VITAMIN A 197
7.9.2 VITAMIN B 198
7.9.3 VITAMIN C 199
7.9.4 VITAMIN D 199
7.9.5 VITAMIN E 200
7.9.6 VITAMIN K 201
7.10 MINERALS 202
7.11 CAROTENOIDS 206
7.11.1 LUTEIN 209
7.11.2 ASTAXANTHIN 210
7.11.3 ZEAXANTHIN 212
7.11.4 B-CAROTENE 213
7.11.5 LYCOPENE 214
7.11.6 OTHER CAROTENOIDS 215
7.12 OTHER TYPES 216
8 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION 219
8.1 INTRODUCTION 220
8.2 FOOD 222
8.2.1 TECHNOLOGICAL ADVANCEMENTS IN FOOD PROCESSING EQUIPMENT, HIGH HEALTHCARE COSTS, AND INCREASED INCIDENCES OF CHRONIC DISEASE TO DRIVE MARKET 222
8.2.2 BAKERY & SNACKS 223
8.2.3 CONFECTIONERY 224
8.2.4 DAIRY 225
8.2.5 MEAT & MEAT PRODUCTS 225
8.2.6 BABY FOOD 226
8.2.7 OTHER FOOD PRODUCTS 227
8.3 BEVERAGES 228
8.3.1 RISING HEALTH-CONSCIOUSNESS, HECTIC LIFESTYLES OF WORKING POPULATION, AND GROWING INCLINATION TOWARD HEALTHY BEVERAGES TO PROPEL MARKET 228
8.3.2 ENERGY DRINKS 229
8.3.3 JUICES 230
8.3.4 HEALTH DRINKS 231
8.4 ANIMAL NUTRITION 231
8.4.1 INCREASE IN DEMAND FOR ANIMAL HEALTH AND NUTRITION TO FUEL DEMAND FOR NUTRACEUTICAL INGREDIENTS IN ANIMAL NUTRITION 231
8.4.2 AMINO ACID IN ANIMAL NUTRITION 232
8.5 DIETARY SUPPLEMENTS 233
8.5.1 CONSUMER AWARENESS AND GROWING INCLINATION TOWARD INITIATIVE-TAKING HEALTH MANAGEMENT TO FOSTER MARKET GROWTH 233
8.6 FOOD FOR SPECIAL MEDICAL PURPOSES (FSMP) 234
8.6.1 ADVANCEMENTS IN MEDICAL RESEARCH, INCREASING AWARENESS ABOUT CLINICAL NUTRITION, AND CONTINUOUS EMERGENCE OF NEW MEDICAL CONDITIONS TO BOOST MARKET GROWTH 234
9 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM 236
9.1 INTRODUCTION 237
9.2 DRY 238
9.2.1 SUPERIOR STABILITY, CONVENIENT HANDLING, AND LONGER SHELF-LIFE TO FUEL DEMAND FOR DRY FORM OF INGREDIENTS 238
9.3 LIQUID 239
9.3.1 EASE OF CONSUMPTION AND FASTER ABSORPTION RATES TO FOSTER DEMAND FOR LIQUID FORM OF INGREDIENTS 239
10 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTION 241
10.1 INTRODUCTION 241
10.2 ADDITIONAL SUPPLEMENTS 243
10.2.1 NEED TO ADDRESS SPECIFIC DEFICIENCIES, MANAGE HEALTH CONDITIONS, AND ENHANCE PHYSICAL APPEARANCE TO BOOST MARKET GROWTH 243
10.2.2 NUTRITION 244
10.2.3 WEIGHT MANAGEMENT 244
10.2.4 SKIN HEALTH 245
10.3 MEDICINAL SUPPLEMENTS 246
10.3.1 INCREASING CONSUMER AWARENESS ABOUT PREVENTIVE HEALTHCARE AND RISING INCIDENCES OF LIFESTYLE-RELATED DISEASES TO DRIVE MARKET 246
10.3.2 GUT HEALTH 246
10.3.3 HEART HEALTH 247
10.3.4 BONE HEALTH 248
10.3.5 IMMUNITY 249
10.3.6 EYE HEALTH 249
10.3.7 OTHER MEDICAL SUPPLEMENTS 249
10.4 SPORTS NUTRITION 250
10.4.1 INCREASED NUTRIENT REQUIREMENTS DUE TO DEMANDING PHYSICAL ACTIVITIES TO DRIVE DEMAND 250
11 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION 252
11.1 INTRODUCTION 253
11.2 NORTH AMERICA 256
11.2.1 US 266
11.2.1.1 Increased consumer demand for fortified food & beverages and rising healthcare costs to drive market 266
11.2.2 CANADA 273
11.2.2.1 High prevalence of inadequate vitamin D and calcium levels, rising food industry, and growing consumer health awareness to propel market 273
11.2.3 MEXICO 280
11.2.3.1 Rise in per capita expenditure on nutritious and healthy foods to fuel demand for nutraceutical ingredients 280
11.3 EUROPE 287
11.3.1 GERMANY 296
11.3.1.1 Growing dietary supplement industry and focus on functional foods to address health concerns to boost market growth 296
11.3.2 UK 303
11.3.2.1 Rising awareness regarding healthy diet and increasing demand for dietary ingredients to drive market 303
11.3.3 FRANCE 310
11.3.3.1 Increased health awareness and strategic government initiatives to foster market 310
11.3.4 ITALY 317
11.3.4.1 High consumption of food supplements and functional foods, widespread acceptance of probiotic products, and rising awareness of associated health benefits to accelerate market growth 317
11.3.5 SPAIN 324
11.3.5.1 Increased pork production to drive market growth 324
11.3.6 REST OF EUROPE 331
11.4 ASIA PACIFIC 337
11.4.1 CHINA 347
11.4.1.1 Growing punk nutrition' trend coupled with changing lifestyles to progress market growth 347
11.4.2 INDIA 354
11.4.2.1 Emphasis on preventive healthcare due to rising hospitalization costs to foster market growth 354
?
11.4.3 JAPAN 361
11.4.3.1 Weather conditions being suitable for microbial growth and focus on fortified foods to boost market growth 361
11.4.4 AUSTRALIA & NEW ZEALAND 368
11.4.4.1 Changing lifestyles, increased purchasing power, and rising spending on nutritional foods to accelerate market growth 368
11.4.5 REST OF ASIA PACIFIC 375
11.5 SOUTH AMERICA 381
11.5.1 BRAZIL 390
11.5.1.1 Improved health consciousness, growing urbanization, health consciousness, and escalating obesity rates to propel market 390
11.5.2 ARGENTINA 397
11.5.2.1 Prevalence of malnutrition and need for nutritious diet to drive market growth 397
11.5.3 REST OF SOUTH AMERICA 404
11.6 REST OF THE WORLD (ROW) 411
11.6.1 MIDDLE EAST 420
11.6.1.1 Increased demand for healthy food amid rising health concerns to foster market growth 420
11.6.2 AFRICA 427
11.6.2.1 Government initiatives for fortification of food with essential vitamins and minerals to boost market growth 427
12 COMPETITIVE LANDSCAPE 434
12.1 OVERVIEW 434
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 435
12.3 REVENUE ANALYSIS 438
12.4 MARKET SHARE ANALYSIS, 2023 439
12.4.1 MARKET RANKING ANALYSIS 440
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 442
12.5.1 STARS 442
12.5.2 EMERGING LEADERS 443
12.5.3 PERVASIVE PLAYERS 443
12.5.4 PARTICIPANTS 443
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 445
12.5.5.1 Company footprint 445
12.5.5.2 Regional footprint 446
12.5.5.3 Type footprint 447
12.5.5.4 Application footprint 448
12.5.5.5 Form footprint 449
12.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023 450
12.6.1 PROGRESSIVE COMPANIES 450
12.6.2 RESPONSIVE COMPANIES 450
12.6.3 DYNAMIC COMPANIES 450
12.6.4 STARTING BLOCKS 450
12.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023 452
12.6.5.1 Key start-ups/SMEs 452
12.6.5.2 Competitive benchmarking of key start-ups/SMEs 453
12.7 COMPANY VALUATION AND FINANCIAL METRICS 453
12.8 BRAND/PRODUCT COMPARISON 456
12.9 COMPETITIVE SCENARIO AND TRENDS 458
12.9.1 PRODUCT LAUNCHES AND ENHANCEMENTS 458
12.9.2 DEALS 464
12.9.3 EXPANSIONS 476
12.9.4 OTHER DEALS/DEVELOPMENTS 484
13 COMPANY PROFILES 486
13.1 KEY PLAYERS 486
13.1.1 CARGILL, INCORPORATED 486
13.1.1.1 Business overview 486
13.1.1.2 Products/Solutions/Services offered 487
13.1.1.3 Recent developments 490
13.1.1.3.1 Deals 490
13.1.1.3.2 Other deals/developments 491
13.1.1.4 MnM view 492
13.1.1.4.1 Right to win 492
13.1.1.4.2 Strategic choices made 492
13.1.1.4.3 Weaknesses and competitive threats 492
13.1.2 ADM 493
13.1.2.1 Business overview 493
13.1.2.2 Products/Solutions/Services offered 494
13.1.2.3 Recent developments 497
13.1.2.3.1 Product launches 497
13.1.2.3.2 Deals 497
13.1.2.3.3 Other deals/developments 500
13.1.2.4 MnM view 502
13.1.2.4.1 Right to win 502
13.1.2.4.2 Strategic choices made 502
13.1.2.4.3 Weaknesses and competitive threats 502
13.1.3 INTERNATIONAL FLAVORS & FRAGRANCES INC. 503
13.1.3.1 Business overview 503
13.1.3.2 Products/Solutions/Services offered 504
13.1.3.3 Recent developments 508
13.1.3.3.1 Product launches 508
13.1.3.3.2 Deals 509
13.1.3.3.3 Other deals/developments 510
13.1.3.4 MnM view 511
13.1.3.4.1 Right to win 511
13.1.3.4.2 Strategic choices made 511
13.1.3.4.3 Weaknesses and competitive threats 511
13.1.4 BASF SE 512
13.1.4.1 Business overview 512
13.1.4.2 Products/Solutions/Services offered 513
13.1.4.3 Recent developments 516
13.1.4.3.1 Product launches and enhancements 516
13.1.4.3.2 Deals 516
13.1.4.3.3 Other deals/developments 517
13.1.4.4 MnM view 518
13.1.4.4.1 Right to win 518
13.1.4.4.2 Strategic choices made 518
13.1.4.4.3 Weaknesses and competitive threats 518
13.1.5 ARLA FOODS AMBA 519
13.1.5.1 Business overview 519
13.1.5.2 Products/Solutions/Services offered 520
13.1.5.3 Recent developments 523
13.1.5.3.1 Product launches 523
13.1.5.3.2 Deals 523
13.1.5.3.3 Other deals/developments 525
13.1.5.4 MnM view 525
13.1.5.4.1 Right to win 525
13.1.5.4.2 Strategic choices made 525
13.1.5.4.3 Weaknesses and competitive threats 526
13.1.6 DSM-FIRMENICH 527
13.1.6.1 Business overview 527
13.1.6.2 Products/Solutions/Services offered 528
13.1.6.3 Recent developments 531
13.1.6.3.1 Product launches 531
13.1.6.3.2 Deals 532
13.1.6.4 MnM view 533
13.1.7 INGREDION 534
13.1.7.1 Business overview 534
13.1.7.2 Products/Solutions/Services offered 535
13.1.7.3 Recent developments 536
13.1.7.3.1 Product launches 536
13.1.7.3.2 Deals 537
13.1.7.3.3 Other deals/developments 538
13.1.7.4 MnM view 539
?
13.1.8 TATE & LYLE 540
13.1.8.1 Business overview 540
13.1.8.2 Products/Solutions/Services offered 541
13.1.8.3 Recent developments 542
13.1.8.3.1 Product launches 542
13.1.8.3.2 Deals 542
13.1.8.3.3 Other deals/developments 544
13.1.8.4 MnM view 546
13.1.9 AJINOMOTO CO., INC. 547
13.1.9.1 Business overview 547
13.1.9.2 Products/Solutions/Services offered 548
13.1.9.3 Recent developments 549
13.1.9.3.1 Deals 549
13.1.9.3.2 Other deals/developments 549
13.1.9.4 MnM view 550
13.1.10 ASSOCIATED BRITISH FOODS PLC 551
13.1.10.1 Business overview 551
13.1.10.2 Products/Solutions/Services offered 552
13.1.10.3 Recent developments 554
13.1.10.3.1 Deals 554
13.1.10.4 MnM view 555
13.1.11 CHR. HANSEN A/S 556
13.1.11.1 Business overview 556
13.1.11.2 Products/Solutions/Services offered 557
13.1.11.3 Recent developments 558
13.1.11.3.1 Product launches and enhancements 558
13.1.11.3.2 Deals 559
13.1.11.3.3 Other deals/developments 561
13.1.11.4 MnM view 562
13.1.12 KYOWA KIRIN CO., LTD 563
13.1.12.1 Business overview 563
13.1.12.2 Products/Solutions/Services offered 564
13.1.12.3 Recent developments 564
13.1.12.4 MnM view 564
13.1.13 GLANBIA PLC 565
13.1.13.1 Business overview 565
13.1.13.2 Products/Solutions/Services offered 566
13.1.13.3 Recent developments 568
13.1.13.3.1 Product launches 568
13.1.13.3.2 Deals 569
13.1.13.3.3 Other deals/developments 569
13.1.13.4 MnM view 570
13.1.14 FONTERRA CO-OPERATIVE GROUP LIMITED 571
13.1.14.1 Business overview 571
13.1.14.2 Products/Solutions/Services offered 572
13.1.14.3 Recent developments 573
13.1.14.3.1 Deals 573
13.1.14.4 MnM view 573
13.1.15 KERRY GROUP PLC 574
13.1.15.1 Business overview 574
13.1.15.2 Products/Solutions/Services offered 575
13.1.15.3 Recent developments 577
13.1.15.3.1 Product launches 577
13.1.15.3.2 Deals 577
13.1.15.3.3 Other deals/developments 578
13.1.15.4 MnM view 579
13.2 OTHER PLAYERS 580
13.2.1 DIVI'S LABORATORIES LIMITED 580
13.2.1.1 Business overview 580
13.2.1.2 Products/Solutions/Services offered 581
13.2.1.3 Recent developments 582
13.2.1.3.1 Product launches 582
13.2.1.4 MnM view 583
13.2.2 ROQUETTE FRERES 584
13.2.2.1 Business overview 584
13.2.2.2 Products/Solutions/Services offered 584
13.2.2.3 Recent developments 585
13.2.2.3.1 Product launches and enhancements 585
13.2.2.3.2 Other deals/developments 586
13.2.2.4 MnM view 586
13.2.3 BENEO 587
13.2.3.1 Business overview 587
13.2.3.2 Products/Solutions/Services offered 587
13.2.3.3 Recent developments 589
13.2.3.3.1 Other deals/developments 589
13.2.3.4 MnM view 589
13.2.4 KEMIN INDUSTRIES, INC. 590
13.2.4.1 Business overview 590
13.2.4.2 Products/Solutions/Services offered 590
13.2.4.3 Recent developments 592
13.2.4.3.1 Product enhancements 592
13.2.4.3.2 Other deals/developments 593
13.2.4.4 MnM view 593
?
13.2.5 GOLDEN GRAIN GROUP LIMITED 594
13.2.5.1 Business overview 594
13.2.5.2 Products/Solutions/Services offered 594
13.2.5.3 Recent developments 595
13.2.5.4 MnM view 595
13.2.6 COSUCRA 596
13.2.7 PURIS 597
13.2.8 PROEON 598
13.2.9 CONAGEN, INC. 599
13.2.10 CHICKP 600
14 ADJACENT & RELATED MARKETS 601
14.1 INTRODUCTION 601
14.2 RESEARCH LIMITATIONS 601
14.3 DIETARY SUPPLEMENTS MARKET 601
14.3.1 MARKET DEFINITION 601
14.3.2 MARKET OVERVIEW 602
14.3.3 DIETARY SUPPLEMENTS MARKET, BY TARGET CONSUMER 602
14.3.4 DIETARY SUPPLEMENTS MARKET, BY REGION 603
14.4 HEALTH INGREDIENTS MARKET 604
14.4.1 MARKET DEFINITION 604
14.4.2 MARKET OVERVIEW 604
14.4.3 HEALTH INGREDIENTS MARKET, BY SOURCE 605
14.4.4 HEALTH INGREDIENTS MARKET, BY REGION 606
15 APPENDIX 607
15.1 DISCUSSION GUIDE 607
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 614
15.3 CUSTOMIZATION OPTIONS 616
15.4 RELATED REPORTS 616
15.5 AUTHOR DETAILS 617
TABLE 1 USD EXCHANGE RATES, 2020-2023 56
TABLE 2 NUTRACEUTICAL INGREDIENTS MARKET SHARE SNAPSHOT,
2024 VS. 2029 (USD MILLION) 72
TABLE 3 GLOBAL PREVALENCE OF ANEMIA ACROSS DIFFERENT POPULATION
GROUPS, 2019 89
TABLE 4 WIDELY USED FORTIFIED FOODS 91
TABLE 5 PERSONALIZED NUTRITION TRENDS AND ADVANCEMENTS 92
TABLE 6 EXAMPLES OF UNITED STATES FDA-APPROVED MEDICAL WEARABLE AND IMPLANTABLE DEVICES 94
TABLE 7 HEALTH ISSUES AND NUTRACEUTICAL INGREDIENTS USED FOR CURE 95
TABLE 8 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS 97
TABLE 9 AVERAGE SELLING PRICES OF TOP THREE TYPES, 2020-2023 (USD/KG) 102
TABLE 10 AVERAGE SELLING PRICE TRENDS, BY REGION, 2020-2023 (USD/KG) 103
TABLE 11 NUTRACEUTICAL INGREDIENTS MARKET: ECOSYSTEM 108
TABLE 12 LIST OF MAJOR PATENTS PERTAINING TO NUTRACEUTICAL INGREDIENTS MARKET, 2014-2024 112
TABLE 13 TOP FIVE EXPORTERS OF NUTRACEUTICAL INGREDIENTS (HS CODE 2936),
2023 (USD THOUSAND) 117
TABLE 14 TOP FIVE IMPORTERS OF NUTRACEUTICAL INGREDIENTS (HS CODE 2936),
2023 (USD THOUSAND) 118
TABLE 15 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES
AND EVENTS, 2024-2025 119
TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 120
TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121
TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 122
TABLE 19 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 123
TABLE 20 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123
TABLE 21 DEFINITIONS AND REGULATIONS FOR NUTRACEUTICAL INGREDIENTS WORLDWIDE 124
TABLE 22 REGULATORY ORGANIZATIONS FOR NUTRACEUTICALS INGREDIENTS WORLDWIDE 127
TABLE 23 SCHEDULE - XI OF FOOD SAFETY AND STANDARDS REGULATIONS FOR LIST OF APPROVED PREBIOTIC INGREDIENTS, 2015 132
TABLE 24 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES
AND THEIR SOURCES 132
TABLE 25 PORTER'S FIVE FORCES IMPACT ON NUTRACEUTICAL INGREDIENTS MARKET 134
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES 138
TABLE 27 KEY BUYING CRITERIA FOR TOP THREE TYPES 139
TABLE 28 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (USD MILLION) 150
TABLE 29 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (USD MILLION) 150
TABLE 30 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (KILO TON) 151
TABLE 31 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (KILO TON) 151
TABLE 32 RECOMMENDED DIETARY ALLOWANCES (RDA) FOR PROTEINS IN DIFFERENT AGE GROUPS (GRAMS/DAY) 152
TABLE 33 FUNCTIONS OF PROTEIN 153
TABLE 34 PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 153
TABLE 35 PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 154
TABLE 36 PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (KILO TON) 154
TABLE 37 PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (KILO TON) 154
TABLE 38 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 156
TABLE 39 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 156
TABLE 40 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (KILO TON) 156
TABLE 41 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (KILO TON) 157
TABLE 42 NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 157
TABLE 43 NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 158
TABLE 44 BRANCHED CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2020-2023 (USD MILLION) 158
TABLE 45 BRANCHED CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2024-2029 (USD MILLION) 159
TABLE 46 BRANCHED CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET,
BY SUB-TYPE, 2020-2023 (USD MILLION) 159
TABLE 47 BRANCHED CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET,
BY SUB-TYPE, 2024-2029 (USD MILLION) 159
TABLE 48 LEUCINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 160
TABLE 49 LEUCINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 160
TABLE 50 ISOLEUCINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 161
TABLE 51 ISOLEUCINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 161
TABLE 52 VALINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 162
TABLE 53 VALINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 162
TABLE 54 LYSINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 163
TABLE 55 LYSINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 163
TABLE 56 METHIONINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 164
TABLE 57 METHIONINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 164
TABLE 58 THREONINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 165
TABLE 59 THREONINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 165
TABLE 60 TRYPTOPHAN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 166
TABLE 61 TRYPTOPHAN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 166
TABLE 62 GLUTAMIC ACID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 167
TABLE 63 GLUTAMIC ACID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 167
TABLE 64 PHENYLALANINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 168
TABLE 65 PHENYLALANINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 168
TABLE 66 OTHER AMINO ACID TYPES: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2020-2023 (USD MILLION) 169
TABLE 67 OTHER AMINO ACID TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION) 169
TABLE 68 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION) 170
TABLE 69 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION) 171
TABLE 70 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON) 171
TABLE 71 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON) 171
TABLE 72 PROBIOTIC COMPONENTS & THEIR BENEFITS 172
TABLE 73 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 174
TABLE 74 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 174
TABLE 75 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (KILO TON) 174
TABLE 76 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (KILO TON) 175
TABLE 77 SPECIFIC PHYTOCHEMICALS AND THEIR POTENTIAL BENEFITS 176
TABLE 78 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION) 176
TABLE 79 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION) 176
TABLE 80 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON) 177
TABLE 81 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON) 177
TABLE 82 PREBIOTIC COMPONENTS & THEIR BENEFITS 178
TABLE 83 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 179
TABLE 84 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 179
TABLE 85 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (KILO TON) 179
TABLE 86 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (KILO TON) 180
TABLE 87 FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION) 181
TABLE 88 FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION) 181
TABLE 89 FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON) 181
TABLE 90 FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON) 182
TABLE 91 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 182
TABLE 92 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 182
TABLE 93 POLYUNSATURATED FATTY ACIDS (PUFAS): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION) 183
TABLE 94 POLYUNSATURATED FATTY ACIDS (PUFAS): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION) 183
TABLE 95 POLYUNSATURATED FATTY ACIDS (PUFAS): NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2020-2023 (USD MILLION) 184
TABLE 96 POLYUNSATURATED FATTY ACIDS (PUFAS): NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2024-2029 (USD MILLION) 184
TABLE 97 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION) 185
TABLE 98 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION) 185
TABLE 99 OMEGA-6 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION) 186
TABLE 100 OMEGA-6 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION) 186
TABLE 101 CONJUGATED LINOLEIC ACID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION) 187
TABLE 102 CONJUGATED LINOLEIC ACID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION) 187
TABLE 103 OMEGA-9 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION) 188
TABLE 104 OMEGA-9 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION) 188
TABLE 105 MEDIUM CHAIN TRIGLYCERIDES: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2020-2023 (USD MILLION) 189
TABLE 106 MEDIUM CHAIN TRIGLYCERIDES: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2024-2029 (USD MILLION) 189
TABLE 107 OTHER FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2020-2023 (USD MILLION) 190
TABLE 108 OTHER FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2024-2029 (USD MILLION) 190
TABLE 109 VITAMINS CLASSIFIED AS MICRONUTRIENTS 191
TABLE 110 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 195
TABLE 111 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 195
TABLE 112 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (KILO TON) 195
TABLE 113 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (KILO TON) 196
TABLE 114 NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 196
TABLE 115 NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 196
TABLE 116 VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 197
TABLE 117 VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 197
TABLE 118 VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 198
TABLE 119 VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 198
TABLE 120 VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 199
TABLE 121 VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 199
TABLE 122 VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 200
TABLE 123 VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 200
TABLE 124 VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 201
TABLE 125 VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 201
TABLE 126 VITAMIN K: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 202
TABLE 127 VITAMIN K: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 202
TABLE 128 MACROMINERALS & THEIR FUNCTIONS 203
TABLE 129 MICROMINERALS & THEIR FUNCTIONS 204
TABLE 130 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 205
TABLE 131 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 205
TABLE 132 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (KILO TON) 205
TABLE 133 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (KILO TON) 206
TABLE 134 SOURCES OF CAROTENOIDS IN FRUITS AND VEGETABLES AND THEIR MEDICINAL PROPERTIES 207
TABLE 135 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 207
TABLE 136 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 208
TABLE 137 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (KILO TON) 208
TABLE 138 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (KILO TON) 208
TABLE 139 NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 209
TABLE 140 NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 209
TABLE 141 LUTEIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 210
TABLE 142 LUTEIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 210
TABLE 143 ASTAXANTHIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 211
TABLE 144 ASTAXANTHIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 211
TABLE 145 ZEAXANTHIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 212
TABLE 146 ZEAXANTHIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 212
TABLE 147 B-CAROTENE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 213
TABLE 148 B-CAROTENE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 213
TABLE 149 LYCOPENE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 214
TABLE 150 LYCOPENE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 215
TABLE 151 OTHER CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2020-2023 (USD MILLION) 216
TABLE 152 OTHER CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION) 216
TABLE 153 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 217
TABLE 154 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 217
TABLE 155 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (KILO TON) 218
TABLE 156 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (KILO TON) 218
TABLE 157 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 221
TABLE 158 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 222
TABLE 159 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 223
TABLE 160 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 223
TABLE 161 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MACRONUTRIENTS 227
TABLE 162 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MICRONUTRIENTS 227
TABLE 163 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 229
TABLE 164 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 229
TABLE 165 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 232
TABLE 166 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 233
TABLE 167 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION) 234
TABLE 168 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET,
BY REGION, 2024-2029 (USD MILLION) 234
TABLE 169 FOOD FOR SPECIAL MEDICAL PURPOSES (FSMP): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION) 235
TABLE 170 FOOD FOR SPECIAL MEDICAL PURPOSES (FSMP): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION) 235
TABLE 171 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2020-2023 (USD MILLION) 238
TABLE 172 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024-2029 (USD MILLION) 238
TABLE 173 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 239
TABLE 174 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 239
TABLE 175 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2020-2023 (USD MILLION) 240
TABLE 176 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION,
2024-2029 (USD MILLION) 240
TABLE 177 BONE-BUILDING NUTRIENTS & THEIR THERAPEUTIC RANGE 248
TABLE 178 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION) 254
TABLE 179 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION) 255
TABLE 180 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON) 255
TABLE 181 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON) 255
TABLE 182 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2020-2023 (USD MILLION) 257
TABLE 183 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2024-2029 (USD MILLION) 258
TABLE 184 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 258
TABLE 185 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 259
TABLE 186 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (KILO TON) 259
TABLE 187 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (KILO TON) 260
TABLE 188 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION) 260
TABLE 189 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION) 261
TABLE 190 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 261
TABLE 191 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 261
TABLE 192 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 262
TABLE 193 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 262
TABLE 194 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 262
TABLE 195 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 263
TABLE 196 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION) 263
TABLE 197 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION) 263
TABLE 198 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION) 264
TABLE 199 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION) 264
TABLE 200 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION) 264
TABLE 201 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION) 265
TABLE 202 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM,
2020-2023 (USD MILLION) 265
TABLE 203 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM,
2024-2029 (USD MILLION) 265
TABLE 204 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (USD MILLION) 267
TABLE 205 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (USD MILLION) 267
TABLE 206 US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 268
TABLE 207 US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 268
TABLE 208 US: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 269
TABLE 209 US: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 269
TABLE 210 US: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 269
TABLE 211 US: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 270
TABLE 212 US: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 270
TABLE 213 US: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 270
TABLE 214 US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 271
TABLE 215 US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 271
TABLE 216 US: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 271
TABLE 217 US: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 272
TABLE 218 US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 272
TABLE 219 US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 272
TABLE 220 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 274
TABLE 221 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 274
TABLE 222 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 275
TABLE 223 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 275
TABLE 224 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 276
TABLE 225 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 276
TABLE 226 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 276
TABLE 227 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 277
TABLE 228 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 277
TABLE 229 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 277
TABLE 230 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 278
TABLE 231 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 278
TABLE 232 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 278
TABLE 233 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 279
TABLE 234 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 279
TABLE 235 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 279
TABLE 236 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 281
TABLE 237 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 281
TABLE 238 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 282
TABLE 239 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 282
TABLE 240 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 283
TABLE 241 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 283
TABLE 242 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL
FATS & OILS TYPE, 2020-2023 (USD MILLION) 283
TABLE 243 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 284
TABLE 244 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 284
TABLE 245 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 284
TABLE 246 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 285
TABLE 247 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 285
TABLE 248 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 285
TABLE 249 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 286
TABLE 250 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 286
TABLE 251 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 286
TABLE 252 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2020-2023 (USD MILLION) 288
TABLE 253 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2024-2029 (USD MILLION) 288
TABLE 254 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 289
TABLE 255 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 289
TABLE 256 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (KILO TON) 290
TABLE 257 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (KILO TON) 290
TABLE 258 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 291
TABLE 259 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 291
TABLE 260 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 292
TABLE 261 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 292
TABLE 262 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 292
TABLE 263 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 293
TABLE 264 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 293
TABLE 265 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 293
TABLE 266 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 294
TABLE 267 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 294
TABLE 268 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 294
TABLE 269 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 295
TABLE 270 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 295
TABLE 271 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 295
TABLE 272 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM,
2020-2023 (USD MILLION) 296
TABLE 273 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM,
2024-2029 (USD MILLION) 296
TABLE 274 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 297
TABLE 275 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 298
TABLE 276 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 298
TABLE 277 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 299
TABLE 278 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 299
TABLE 279 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 299
TABLE 280 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 300
TABLE 281 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 300
TABLE 282 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 300
TABLE 283 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 301
TABLE 284 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 301
TABLE 285 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 301
TABLE 286 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 302
TABLE 287 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 302
TABLE 288 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 302
TABLE 289 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 303
TABLE 290 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (USD MILLION) 304
TABLE 291 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (USD MILLION) 305
TABLE 292 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 305
TABLE 293 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 306
TABLE 294 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN
AMINO ACID TYPE, 2020-2023 (USD MILLION) 306
TABLE 295 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 306
TABLE 296 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 307
TABLE 297 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 307
TABLE 298 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 307
TABLE 299 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 308
TABLE 300 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 308
TABLE 301 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 308
TABLE 302 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 309
TABLE 303 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 309
TABLE 304 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 309
TABLE 305 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 310
TABLE 306 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 311
TABLE 307 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 312
TABLE 308 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 312
TABLE 309 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 313
TABLE 310 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 313
TABLE 311 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 313
TABLE 312 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 314
TABLE 313 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 314
TABLE 314 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 314
TABLE 315 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 315
TABLE 316 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 315
TABLE 317 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 315
TABLE 318 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 316
TABLE 319 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 316
TABLE 320 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 316
TABLE 321 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 317
TABLE 322 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 318
TABLE 323 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 318
TABLE 324 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 319
TABLE 325 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 319
TABLE 326 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 320
TABLE 327 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 320
TABLE 328 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 320
TABLE 329 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 321
TABLE 330 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 321
TABLE 331 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 321
TABLE 332 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 322
TABLE 333 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 322
TABLE 334 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 322
TABLE 335 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 323
TABLE 336 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 323
TABLE 337 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 323
TABLE 338 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 325
TABLE 339 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 325
TABLE 340 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 326
TABLE 341 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 326
TABLE 342 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 327
TABLE 343 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 327
TABLE 344 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 327
TABLE 345 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 328
TABLE 346 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 328
TABLE 347 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 328
TABLE 348 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 329
TABLE 349 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 329
TABLE 350 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 329
TABLE 351 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 330
TABLE 352 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 330
TABLE 353 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 330
TABLE 354 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 331
TABLE 355 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 332
TABLE 356 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION) 332
TABLE 357 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION) 333
TABLE 358 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 333
TABLE 359 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 333
TABLE 360 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 334
TABLE 361 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 334
TABLE 362 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 334
TABLE 363 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 335
TABLE 364 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION) 335
TABLE 365 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION) 335
TABLE 366 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION) 336
TABLE 367 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION) 336
TABLE 368 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION) 336
TABLE 369 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION) 337
TABLE 370 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2020-2023 (USD MILLION) 339
TABLE 371 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2024-2029 (USD MILLION) 339
TABLE 372 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 340
TABLE 373 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 340
TABLE 374 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (KILO TON) 341
TABLE 375 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (KILO TON) 341
TABLE 376 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION) 342
TABLE 377 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION) 342
TABLE 378 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 343
TABLE 379 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 343
TABLE 380 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 343
TABLE 381 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 344
TABLE 382 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 344
TABLE 383 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 344
TABLE 384 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 345
TABLE 385 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 345
TABLE 386 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION) 345
TABLE 387 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION) 346
TABLE 388 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 346
TABLE 389 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 346
TABLE 390 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM,
2020-2023 (USD MILLION) 347
TABLE 391 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM,
2024-2029 (USD MILLION) 347
TABLE 392 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 348
TABLE 393 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 349
TABLE 394 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 349
TABLE 395 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 350
TABLE 396 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 350
TABLE 397 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 350
TABLE 398 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 351
TABLE 399 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 351
TABLE 400 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 351
TABLE 401 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 352
TABLE 402 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 352
TABLE 403 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 352
TABLE 404 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 353
TABLE 405 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 353
TABLE 406 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 353
TABLE 407 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 354
TABLE 408 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 355
TABLE 409 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 356
TABLE 410 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 356
TABLE 411 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 357
TABLE 412 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 357
TABLE 413 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 357
TABLE 414 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 358
TABLE 415 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 358
TABLE 416 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 358
TABLE 417 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 359
TABLE 418 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 359
TABLE 419 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 359
TABLE 420 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 360
TABLE 421 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 360
TABLE 422 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 360
TABLE 423 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 361
TABLE 424 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 362
TABLE 425 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 363
TABLE 426 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 363
TABLE 427 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 364
TABLE 428 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 364
TABLE 429 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 364
TABLE 430 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 365
TABLE 431 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 365
TABLE 432 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 365
TABLE 433 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 366
TABLE 434 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 366
TABLE 435 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 366
TABLE 436 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 367
TABLE 437 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 367
TABLE 438 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 367
TABLE 439 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 368
TABLE 440 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2020-2023 (USD MILLION) 369
TABLE 441 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2024-2029 (USD MILLION) 369
TABLE 442 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY AMINO ACID TYPE, 2020-2023 (USD MILLION) 370
TABLE 443 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY AMINO ACID TYPE, 2024-2029 (USD MILLION) 370
TABLE 444 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 371
TABLE 445 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 371
TABLE 446 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 371
TABLE 447 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 372
TABLE 448 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 372
TABLE 449 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 372
TABLE 450 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION) 373
TABLE 451 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY VITAMIN TYPE, 2024-2029 (USD MILLION) 373
TABLE 452 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY CAROTENOID TYPE, 2020-2023 (USD MILLION) 373
TABLE 453 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY CAROTENOID TYPE, 2024-2029 (USD MILLION) 374
TABLE 454 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY APPLICATION, 2020-2023 (USD MILLION) 374
TABLE 455 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET,
BY APPLICATION, 2024-2029 (USD MILLION) 374
TABLE 456 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 375
TABLE 457 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 376
TABLE 458 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION) 376
TABLE 459 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION) 377
TABLE 460 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 377
TABLE 461 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 377
TABLE 462 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 378
TABLE 463 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 378
TABLE 464 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 378
TABLE 465 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 379
TABLE 466 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION) 379
TABLE 467 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION) 379
TABLE 468 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION) 380
TABLE 469 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION) 380
TABLE 470 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION) 380
TABLE 471 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION) 381
TABLE 472 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2020-2023 (USD MILLION) 382
TABLE 473 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY,
2024-2029 (USD MILLION) 382
TABLE 474 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 382
TABLE 475 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 383
TABLE 476 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (KILO TON) 383
TABLE 477 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (KILO TON) 384
TABLE 478 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION) 384
TABLE 479 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION) 385
TABLE 480 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 385
TABLE 481 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 385
TABLE 482 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 386
TABLE 483 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 386
TABLE 484 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 386
TABLE 485 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 387
TABLE 486 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION) 387
TABLE 487 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION) 387
TABLE 488 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION) 388
TABLE 489 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION) 388
TABLE 490 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION) 388
TABLE 491 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION) 389
TABLE 492 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM,
2020-2023 (USD MILLION) 389
TABLE 493 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM,
2024-2029 (USD MILLION) 389
TABLE 494 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 391
TABLE 495 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 391
TABLE 496 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 392
TABLE 497 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 392
TABLE 498 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 393
TABLE 499 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 393
TABLE 500 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 393
TABLE 501 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 394
TABLE 502 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 394
TABLE 503 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 394
TABLE 504 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 395
TABLE 505 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 395
TABLE 506 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 395
TABLE 507 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 396
TABLE 508 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 396
TABLE 509 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 396
TABLE 510 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 398
TABLE 511 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 398
TABLE 512 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION) 399
TABLE 513 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION) 399
TABLE 514 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 400
TABLE 515 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 400
TABLE 516 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 400
TABLE 517 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 401
TABLE 518 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 401
TABLE 519 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 401
TABLE 520 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 402
TABLE 521 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 402
TABLE 522 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION) 402
TABLE 523 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION) 403
TABLE 524 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 403
TABLE 525 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 403
TABLE 526 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2020-2023 (USD MILLION) 405
TABLE 527 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY TYPE, 2024-2029 (USD MILLION) 405
TABLE 528 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY AMINO ACID TYPE, 2020-2023 (USD MILLION) 406
TABLE 529 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY AMINO ACID TYPE, 2024-2029 (USD MILLION) 406
TABLE 530 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 407
TABLE 531 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 407
TABLE 532 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 407
TABLE 533 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 408
TABLE 534 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 408
TABLE 535 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 408
TABLE 536 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION) 409
TABLE 537 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY VITAMIN TYPE, 2024-2029 (USD MILLION) 409
TABLE 538 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY CAROTENOID TYPE, 2020-2023 (USD MILLION) 409
TABLE 539 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY CAROTENOID TYPE, 2024-2029 (USD MILLION) 410
TABLE 540 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET,
BY APPLICATION, 2020-2023 (USD MILLION) 410
TABLE 541 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION) 410
TABLE 542 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBREGION, 2020-2023 (USD MILLION) 411
TABLE 543 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBREGION, 2024-2029 (USD MILLION) 412
TABLE 544 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 412
TABLE 545 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 413
TABLE 546 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (KILO TON) 413
TABLE 547 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (KILO TON) 414
TABLE 548 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION) 414
TABLE 549 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION) 415
TABLE 550 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 415
TABLE 551 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 415
TABLE 552 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 416
TABLE 553 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 416
TABLE 554 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 416
TABLE 555 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 417
TABLE 556 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION) 417
TABLE 557 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION) 417
TABLE 558 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION) 418
TABLE 559 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION) 418
TABLE 560 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION) 418
TABLE 561 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION) 419
TABLE 562 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM,
2020-2023 (USD MILLION) 419
TABLE 563 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM,
2024-2029 (USD MILLION) 419
TABLE 564 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 421
TABLE 565 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 421
TABLE 566 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION) 422
TABLE 567 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION) 422
TABLE 568 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 423
TABLE 569 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 423
TABLE 570 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 423
TABLE 571 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 424
TABLE 572 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 424
TABLE 573 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 424
TABLE 574 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 425
TABLE 575 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 425
TABLE 576 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION) 425
TABLE 577 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION) 426
TABLE 578 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 426
TABLE 579 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 426
TABLE 580 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2020-2023 (USD MILLION) 428
TABLE 581 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,
2024-2029 (USD MILLION) 428
TABLE 582 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2020-2023 (USD MILLION) 429
TABLE 583 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,
2024-2029 (USD MILLION) 429
TABLE 584 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION) 430
TABLE 585 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION) 430
TABLE 586 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION) 430
TABLE 587 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION) 431
TABLE 588 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION) 431
TABLE 589 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION) 431
TABLE 590 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2020-2023 (USD MILLION) 432
TABLE 591 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE,
2024-2029 (USD MILLION) 432
TABLE 592 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2020-2023 (USD MILLION) 432
TABLE 593 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE,
2024-2029 (USD MILLION) 433
TABLE 594 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2020-2023 (USD MILLION) 433
TABLE 595 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,
2024-2029 (USD MILLION) 433
TABLE 596 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL INGREDIENTS VENDORS 435
TABLE 597 NUTRACEUTICAL INGREDIENTS MARKET: DEGREE OF COMPETITION 440
TABLE 598 NUTRACEUTICAL INGREDIENTS MARKET: REGIONAL FOOTPRINT 446
TABLE 599 NUTRACEUTICAL INGREDIENTS MARKET: TYPE FOOTPRINT 447
TABLE 600 NUTRACEUTICAL INGREDIENTS MARKET: APPLICATION FOOTPRINT 448
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security